Edward J. Dulac III

EVP, Chief Financial Officer

EVP, Chief Financial Officer at Intellia Therapeutics, Inc., filing insider transactions between 2026-07-02 and 2026-07-22.

Total Purchases

—

0 transactions

Total Sales

$175K

2 transactions

Companies Traded

2 total filings

Active Since

2026-07-02

Last: 2026-07-22

Companies

Intellia Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-22	NTLA	Sale	8,111	$11.25	$91K	148.2K	SEC ↗
2026-07-02	NTLA	Sale	4,677	$18.00	$84K	156.3K	SEC ↗